bioRxivImmunologyPreprint
Spatially organized inflammatory myeloid-CD8+ T cell aggregates linked to Merkel-cell Polyomavirus driven Reorganization of the Tumor Microenvironment
Maximilian HaistiD, Magdalena MatusiakiD, Yuqi TaniD, S. ZimmeriD, Henner M. StegeiD, Tim Noah KempcheniD, Silke Mitschke, Pauline ChuiD, Beate Weidenthaler‐BarthiD, Graham L. BarlowiD, Friederike Rogall, Antonio Delgado‐GonzáleziD, Marc‐Andrea BaertschiD, Silvia AlbertiniiD, Marisa GariglioiD, Cinzia BorgognaiD, Yury GoltseviD, Stephan GrabbeiD, John W. HickeyiD, Garry P. NolaniD
Abstract
Merkel cell carcinoma (MCC) is an aggressive skin cancer with high propensity for metastasis, caused by Merkel-cell-polyomavirus (MCPyV), or chronic UV-light-exposure. How MCPyV spatially modulates immune responses within the tumor microenvironment and how such are linked to patient outcomes remains unknown. We interrogated the cellular and transcriptional landscapes of 60 MCC-patients using a combination of multiplex proteomics, in-situ RNA-hybridization, and spatially oriented transcriptomics. We identified a spatial co-enrichment of activated CD8+ T-cells and CXCL9+PD-L1+ macrophages at the invasive front of virus-positive MCC. This spatial immune response pattern was conserved in another virus-positive tumor, HPV+ head-and-neck cancer. Importantly, we show that virus-negativity correlated with high risk of metastasis through low CD8+ T-cell infiltration and the enrichment of cancer-associated-fibroblasts at the tumor boundary. By contrast, responses to immune-checkpoint blockade (ICB) were independent of viral-status but correlated with the presence of a B-cell-enriched spatial contexts. Our work is the first to reveal distinct immune-response patterns between virus-positive and virus-negative MCC and their impact on metastasis and ICB-response.
- organism: human
- assay: proteomics
- assay: spatial transcriptomics
- research focus: cell type annotation
- research focus: spatial domain detection
- approach: experimental assay
- Citations
- 4
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An immunocompetent model of MCPyV-driven Merkel cell carcinoma reveals tumor evolution under immune selection
James M. Regan, Xiaomei Li, … Jianxin You·bioRxiv·Jul 13, 2026
- Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma
G. J. Starrett, M. Thakuria, … J. A. DeCaprio·bioRxiv·Mar 24, 2019
- B cell responses specific for polyomavirus-derived oncoprotein are predictive of Merkel cell carcinoma tumor control
Haroldo J. Rodriguez, Allison Jeanne Remington, … Justin J. Taylor·bioRxiv·Jul 22, 2025
- Integrated Spatial Multi-omic Profiling Identifies HSV-associated Inflammatory Macrophage Niches Linked to Oncolytic Virotherapy Response in Melanoma
Emma Wagner, Samuel Legg, … Amanda Kirane·bioRxiv·May 21, 2026
- An immunocompetent Merkel cell carcinoma model for preclinical studies
Monique Elise Verhaegen, Simar Bhatia, … Andrzej Antoni Dlugosz·bioRxiv·Jun 26, 2026
- Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel Cell Carcinoma
S. Muralidharan, T. Kervarrec, … M. Samimi·bioRxiv·Feb 6, 2022